Back to Search Start Over

Chlamydia suis and Chlamydia trachomatis induce multifunctional CD4 T cells in pigs

Authors :
François Meurens
Mario Delgado-Ortega
Tobias Käser
J. Erickson
Jo-Anne R. Dillon
Ken Lai
Stewart Walker
Glenn Hamonic
Volker Gerdts
J.A. Pasternak
Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac)
University of Saskatchewan [Saskatoon] (U of S)
North Carolina State University [Raleigh] (NC State)
University of North Carolina System (UNC)
Biologie, Epidémiologie et analyse de risque en Santé Animale (BIOEPAR)
Institut National de la Recherche Agronomique (INRA)
Source :
Vaccine, Vaccine, Elsevier, 2017, 35 (1), pp.91-100. ⟨10.1016/j.vaccine.2016.11.050⟩
Publication Year :
2017
Publisher :
HAL CCSD, 2017.

Abstract

Chlamydia trachomatis infections are the most prominent bacterial sexually-transmitted disease world-wide and a lot of effort is put into the development of an effective vaccine. Pigs have been shown to be a valuable animal model for C. trachomatis vaccine development. The aim of this study was to decipher the T-cell-mediated immune response to chlamydial infections including C. trachomatis and C. suis , the chlamydia species naturally infecting pigs with a demonstrated zoonotic potential. Vaginal infection of pigs with C. suis and C. trachomatis lasted from 3 to 21 days and intra-uterine infection was still present after 21 days in 3 out of 5 C. suis - and 4 out of 5 C. trachomatis -inoculated animals and caused severe pathological changes. Humoral immune responses including neutralizing antibodies were found predominantly in response to C. suis starting at 14 days post inoculation. The T-cell-mediated immune responses to C. trachomatis and C. suis -infections started at 7 days post inoculation and consisted mainly of CD4 + T cells which were either IFN-γ single cytokine-producing or IFN-γ/TNF-α double cytokine-producing T-helper 1 cells. IL-17-producing CD4 + T cells were rare or completely absent. The T-cell-mediated immune responses were triggered by both homologous or heterologous re-stimulation indicating that cross-protection between the two chlamydia species is possible. Thus, having access to a working genital C. suis and C. trachomatis infection model, efficient monitoring of the host-pathogen interactions, and being able to accurately assess the responses to infection makes the pig an excellent animal model for vaccine development which also could bridge the gap to the clinical phase for C. trachomatis vaccine research.

Details

Language :
English
ISSN :
0264410X
Database :
OpenAIRE
Journal :
Vaccine, Vaccine, Elsevier, 2017, 35 (1), pp.91-100. ⟨10.1016/j.vaccine.2016.11.050⟩
Accession number :
edsair.doi.dedup.....80737cd747cc49e14764db13186a1058
Full Text :
https://doi.org/10.1016/j.vaccine.2016.11.050⟩